PLGF1 Human, 132 a.a.

Placental Growth Factor-1, 132 a.a. Human Recombinant
Cat. No.
BT28435
Source

Escherichia Coli.

Synonyms

PIGF, PGF, PLGF-1.

Appearance

Sterile Filtered White lyophilized (freeze-dried) powder.

Purity

Greater than 95.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Placental Growth Factor-1 Human Recombinant produced in E.Coli is a non-glycosylated, disulfide-linked homodimer consisting of 2x132 amino acid polypeptide chains, having a total molecular mass of approximately 29.7kDa.

PLGF1 is purified by proprietary chromatographic techniques.

Product Specs

Introduction

PLGF, a key player in angiogenesis, promotes the growth and movement of endothelial cells, essential for blood vessel formation. It exerts its effects by binding to the vegfr-1/flt1 receptor.

Description

Recombinant Human Placental Growth Factor-1, produced in E. coli, is a non-glycosylated, disulfide-linked homodimer. Each protein molecule comprises two polypeptide chains, each consisting of 132 amino acids, resulting in a total molecular weight of approximately 29.7kDa. The purification process involves specialized chromatographic techniques.

Physical Appearance

Sterile Filtered White lyophilized (freeze-dried) powder.

Formulation

The product is lyophilized, or freeze-dried, from a concentrated solution (0.2µm filtered) in 10mM Sodium Phosphate buffer with a pH of 7.5.

Solubility

To reconstitute the lyophilized Placental Growth Factor-1, it is recommended to dissolve it in sterile 18MΩ-cm H2O to a concentration of at least 100µg/ml. This solution can be further diluted as needed using other aqueous solutions.

Stability

Lyophilized PLGF1 remains stable for 3 weeks at room temperature, but for long-term storage, it is recommended to keep it desiccated below -18°C. After reconstitution, Placental Growth Factor-1 should be stored at 4°C for a period of 2-7 days. For extended storage, it should be kept below -18°C. Repeated freezing and thawing of the product should be avoided.

Purity

The purity is determined to be greater than 95.0% using the following methods:
(a) Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) analysis.
(b) Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) analysis.

Biological Activity

The biological activity is assessed based on the protein's ability to induce chemotaxis, or directed movement, of human monocytes within a concentration range of 1.0-10.0 ng/ml.

Synonyms

PIGF, PGF, PLGF-1.

Source

Escherichia Coli.

Amino Acid Sequence

MLPAVPPQQW ALSAGNGSSE VEVVPFQEVW GRSYCRALER LVDVVSEYPS EVEHMFSPSC VSLLRCTGCC GDENLHCVPV ETANVTMQLL KIRSGDRPSY VELTFSQHVR CECRPLREKM KPERCGDAVP RR.

Product Science Overview

Introduction

Placental Growth Factor-1 (PlGF-1) is a member of the vascular endothelial growth factor (VEGF) family, which plays a crucial role in angiogenesis and vasculogenesis. This article delves into the background, structure, and significance of PlGF-1, specifically focusing on the human recombinant form consisting of 132 amino acids.

Structure and Characteristics

PlGF-1 is a non-glycosylated, disulfide-linked homodimer consisting of two 132 amino acid polypeptide chains . The molecular mass of this recombinant protein is approximately 29.7 kDa . It is produced in E. coli and purified using proprietary chromatographic techniques .

Biological Function

PlGF-1 is involved in various physiological and pathological processes, including:

  • Angiogenesis: It promotes the formation of new blood vessels from pre-existing ones.
  • Vasculogenesis: It aids in the formation of blood vessels during embryonic development.
  • Wound Healing: PlGF-1 accelerates the healing process by enhancing blood supply to the affected area.
  • Inflammation: It plays a role in inflammatory responses by recruiting immune cells to the site of inflammation.
Clinical Significance

PlGF-1 has been extensively studied for its role in pregnancy-related conditions, particularly pre-eclampsia. Pre-eclampsia is a serious complication characterized by high blood pressure and proteinuria during pregnancy . PlGF-based testing is used to diagnose and manage this condition, helping to predict and monitor the risk of developing pre-eclampsia .

Recombinant Production

The recombinant form of PlGF-1 is produced using E. coli expression systems. This method ensures high purity and activity of the protein, making it suitable for various research and clinical applications . The recombinant protein is typically lyophilized and can be reconstituted for use in experiments .

Applications

Recombinant PlGF-1 is used in several research and clinical settings, including:

  • Diagnostic Testing: It is used in assays to diagnose and monitor pre-eclampsia.
  • Therapeutic Research: Studies are exploring its potential in treating conditions like ischemic heart disease and peripheral artery disease.
  • Basic Research: It serves as a tool to study angiogenesis, vasculogenesis, and related cellular processes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.